MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board

September 17, 2009

SCOTTSDALE, Ariz., Sept. 17 /PRNewswire/ -- MedTrust Online, a world-leading provider of clinically-useful knowledge for oncologists seeking therapy options for challenging patient cancer cases, has surpassed 5,000 registered users on its free portal, Oncocentric.com. MedTrust Online also announced today that world-renowned oncologist Dr. Henry Friedman has joined MedTrust Online's growing board of oncology advisors.

"5,000 users is concrete validation that our portal can answer the critical need of oncologists for the latest medical knowledge," stated President and CEO Chris Yoo, Ph.D. "And we are honored to have Dr. Friedman join our illustrious oncology advisory board. The rapid growth in our network of users is a direct result of having the top experts available to help practicing oncologists every day through our portal."

With the addition of Dr. Henry Friedman, Deputy Director of The Preston Robert Tisch Brain Tumor Center at Duke, MedTrust Online continues to attract the brightest minds in new therapeutics and world-renowned cancer care experts.

"I personally believe that targeted personalized therapy is the wave of the future and should be accessible to everyone," stated Dr. Friedman. "I am excited to join MedTrust Online and contribute to making that statement not only a possibility, but a reality."

MedTrust Online also announced a contract with Prometheus Laboratories, another leader in the promising group of companies offering molecular diagnostics in oncology.

"We are pleased to add Prometheus Laboratories as a new content provider to our portal," said Chief Business Officer Russell Clark. "Each new molecular diagnostics customer adds important content that helps our oncologists identify the most appropriate diagnostic and therapeutic options for their patients and provides our customers with important new channels into the oncology market."

About MedTrust Online:

Founded by leaders of the Translational Genomics Research Institute (TGen), MedTrust Online (MTOL) helps cancer doctors practice the most precise medicine for their patients by providing best practice knowledge about the most difficult cases. Through the portal, www.oncocentric.com, any oncologist can find important diagnostic and treatment information and communicate with experts about the best options for individualized therapy. MTOL brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to integrate and present the latest in cutting-edge cancer care. This knowledge is presented as a free resource to doctors in a comprehensive yet concise way unavailable anywhere else.

SOURCE MedTrust Online